Browsing by Yonsei Author : Kim, Jae Hoon

eperson profile image
Name:
Kim, Jae Hoon [김재훈]
orcid http://orcid.org/0000-0001-6599-7065
Department :
College of Medicine (의과대학) - Dept. of Obstetrics and Gynecology (산부인과학교실)
Scopus ID :
Scopus (34771509800)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 223

This table browses all dspace content
Issue DateTitleJournal Title
2023High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer ONCOLOGY REPORTS
2023High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer ANNALS OF LABORATORY MEDICINE
2022THERAPEUTIC EFFECT OF SURGICAL DEBULKING OF METASTATIC LYMPH NODES IN CERVICAL CANCER STAGE IIICR: A PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL (DEBULK TRIAL)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022PROSPECTIVE MULTI-INSTITUTIONAL PHASE III TRIAL OF STANDARD OF CARE THERAPY WITH OR WITHOUT STEROTACTIC ABLATIVE RADIATION THERAPY FOR RECURRENT OVARIAN CANCER (SABR-ROC, KGOG 3064/KROG 2204)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022LATE-BREAKING ABSTRACT PRESENTATION: COMPARATIVE EFFECTIVENESS OF HIPEC FOLLOWING INTERVAL CYTOREDUCTIVE SURGERY IN PATIENTS WITH ADVANCED-STAGE OVARIAN CANCER UNDERGOING NEOADJUVANT CHEMOTHERAPY: MULTICENTER, PROSPECTIVE, COHORT STUDY (KGOG 3042)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022High FKBPL expression contributes to cell proliferation by regulating the cell cycle and affects prognosis in ovarian cancer patientsINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF TRAFFICKING PROTEIN TRANSMEMBRANE P24 TRAFFICKING PROTEIN9 PROMOTES POOR PROGNOSIS OF EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes CLINICAL CANCER RESEARCH
2022TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis CANCER GENOMICS & PROTEOMICS
2022RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancerJOURNAL OF GENE MEDICINE
2022NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
2022Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047)INTERNATIONAL JOURNAL OF CANCER
2022Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients AMERICAN JOURNAL OF CANCER RESEARCH
2022BRAK and APRIL as novel biomarkers for ovarian tumorsBIOMARKERS IN MEDICINE
2022NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59 SCIENTIFIC REPORTS
2022Identification of a novel gene signature in second-trimester amniotic fluid for the prediction of preterm birth SCIENTIFIC REPORTS
2022Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models CANCERS
2022Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer CURRENT ISSUES IN MOLECULAR BIOLOGY
2021Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer CANCER SCIENCE
2021CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer CANCER GENOMICS & PROTEOMICS
2021LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells AUTOPHAGY
2021Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial EXPERIMENTAL AND THERAPEUTIC MEDICINE
2021Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trialLANCET ONCOLOGY
2021Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021The Combination of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) is an Effective Prognostic Biomarker in Cervical CancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
2021SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor MicroenvironmentCANCERS
2021Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma MOLECULAR ONCOLOGY
2021MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors PLOS PATHOGENS
2020Convergence of Plasma Metabolomics and Proteomics Analysis to Discover Signatures of High-Grade Serous Ovarian Cancer CANCERS
2020Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia: A Randomized, Open-labeled, Multicentered, Phase IV StudyCLINICAL THERAPEUTICS
2020TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels CANCERS
2020Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer CANCER GENOMICS & PROTEOMICS
2020CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancerGYNECOLOGIC ONCOLOGY
2020HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors NATURE COMMUNICATIONS
2019Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer BMC CANCER
2019Clear Cell Carcinoma Arising from Endometriosis at the Cesarean Scar Site: A Case Report Archives of Clinical and Medical Case Reports
2019Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian CancerCancer genomics & Proteomics
2019ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer CANCERS
2019Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growthINTERNATIONAL JOURNAL OF HYPERTHERMIA
2019Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer CANCER RESEARCH AND TREATMENT
2018Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview JOURNAL OF KOREAN MEDICAL SCIENCE
2018Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer BIOMED RESEARCH INTERNATIONAL
2018Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas Obstetrics & Gynecology Science
2018Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression PLOS ONE
2018Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance JOURNAL OF CLINICAL INVESTIGATION
2018Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancerBRITISH JOURNAL OF CANCER
2018DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer CANCERS

Browse

Links